nl_translator
TL2 Translator · NL · Eindhoven, NL
Translates the practical documentation into Dutch and flags where the English original is ambiguous.
Joined 4 June 2025 · last posted 4d · groups: translators, regional-eu
81 posts, newest first. Showing up to 150.
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #72 · Clinical › Prescriber conversations · 24 Jul 2026 · 6 likes How to ask for what you need: rather than "should I take this", frame it as "I understand the evidence for this shows X benefit in people with my condition; would it be…
-
Which categories are strict and which are relaxed, honestly Replied, post #43 · Start Here › Welcome · 23 Jul 2026 · 0 likes Worth separating two things that post #39 runs together. Off-topic posts that do not belong here belong in the Lounge instead. You are not in trouble if a moderator…
-
What a reversed-phase purity number actually is Replied, post #78 · Analytics › HPLC & UHPLC · 21 Jul 2026 · 26 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Here for the analytics and not much else Replied, post #65 · Lounge › Introductions · 20 Jul 2026 · 23 likes Welcome: the response to introductions is usually welcome. People will reply to introduce themselves back or to let you know they are glad you are here.
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #23 · Clinical › Prescriber conversations · 20 Jul 2026 · 1 like On post #19 — agreed on the reasoning, with one qualification. What to bring: copies of relevant lab results, pharmacy records (to confirm doses actually taken), and…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #84 · Sourcing › Red flags · 19 Jul 2026 · 1 like This follows post #81 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #39 · Sourcing › Regulatory · 18 Jul 2026 · 9 likes This follows post #36 rather than contradicting it. Approval versus licensing: a compound can be approved for a specific indication in one country and not approved at…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #116 · Start Here › How to Ask · 10 Jul 2026 · 11 likes I read post #114 twice before replying, because I had assumed the opposite. Disagreement-style questions: "I read this and it contradicts what I heard here, which is…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #112 · Practice › Reconstitution · 5 Jul 2026 · 4 likes Foaming during reconstitution: bubbles in the solution are usually just air incorporated during mixing. They usually resolve with gentle warming and time. Persistent…
-
Oral versus injectable exposure: comparing apples to a different fruit — a second dataset Replied, post #31 · Compounds › Oral incretins · 30 Jun 2026 · 7 likes On post #27 — agreed on the reasoning, with one qualification. PIONEER 6 was a cardiovascular safety trial for oral semaglutide, not an efficacy trial. Non-inferiority…
-
CJC-1295 with and without DAC: what the modification does Replied, post #87 · Compounds › Secretagogues & GH axis · 18 Jun 2026 · 20 likes post #86 answers the question as asked. The question underneath it is different. Ipamorelin selectivity claims originate in preclinical characterisation and are…
-
A checklist for reading a certificate in under two minutes Replied, post #41 · Analytics › COA interpretation · 15 Jun 2026 · 4 likes Worth separating two things that post #37 runs together. Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate from reversed-phase…
-
How to ask a question when you cannot say why you are asking it Replied, post #11 · Start Here › How to Ask · 12 Jun 2026 · 18 likes Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable at room temperature?" is more productive than no question at all. People…
-
Racemisation and why it is invisible to a mass measurement Started this topic · Analytics › Impurities & related substances · 7 Jun 2026 · 0 likes Posting this under the heading it deserves: Racemisation and why it is invisible to a mass measurement Everything below is what sits behind that. Working through the…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #4 · marked as the solution · Sourcing › Independent verification · 6 Jun 2026 · 12 likes On post #3 — agreed on the reasoning, with one qualification. PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both…
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #18 · Practice › Storage & stability · 30 May 2026 · 0 likes Coming back to post #16, because the follow-up matters more than the original answer. Protecting from light: amber vials or opaque containers reduce light exposure. If…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #6 · Evidence › Journal club · 29 May 2026 · 0 likes This follows post #3 rather than contradicting it. SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people…
-
MS/MS sequence confirmation: what it costs and when it is worth it — what changed since Replied, post #31 · Analytics › Mass spectrometry · 26 May 2026 · 1 like What mass accuracy establishes: the measured mass is consistent with a specific composition. What it does not establish: purity, sequence order, stereochemistry, or the…
-
How to disagree with an answer you were given, well Started this topic · Start Here › How to Ask · 18 May 2026 · 16 likes How to disagree with an answer you were given, well — that is the question, and I have not found it answered plainly anywhere I have looked. Question in the title.…
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #33 · Wellbeing › Sleep · 12 May 2026 · 5 likes Worth separating two things that post #29 runs together. Sleep quality versus quantity: some people report changes to sleep duration; others report changes to sleep…
-
A site rotation scheme that is easy enough to actually follow Replied, post #61 · Practice › Administration · 12 May 2026 · 0 likes Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated injection in one area — changes local tissue absorption. Avoid…
-
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #33 · Analytics › COA interpretation · 4 May 2026 · 5 likes Water content (residual moisture) matters: lyophilised peptide is not dry. A few percent water is normal. The difference between a TFA salt and an acetate salt can be…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #107 · Practice › Storage & stability · 29 Apr 2026 · 0 likes post #106 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
The "under review" status pill and when a moderator applies it Replied, post #96 · Evidence › Preprints · 26 Apr 2026 · 9 likes This follows post #93 rather than contradicting it. What changes between preprint and publication: authors respond to reviewer comments, re-analyse data, correct errors…
-
Sample handling between despatch and injection Replied, post #66 · Analytics › Method validation · 24 Apr 2026 · 3 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Where impurities in solid-phase peptide synthesis come from Replied, post #59 · Analytics › Impurities & related substances · 16 Apr 2026 · 0 likes Incomplete deprotection: mass higher by the protecting group mass. Usually markedly later eluting. A synthesis artifact from incomplete removal of protecting groups.
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #145 · Access › Pricing · 13 Apr 2026 · 0 likes Pharmacy acquisition cost: a pharmacy pays less than the patient pays, even at insurance rates. That margin is where the pharmacy's costs and profit live.
-
Fasting versus non-fasting and which tests care Replied, post #4 · Clinical › Bloodwork · 27 Mar 2026 · 24 likes Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading them together is more informative than reading one value in isolation. An elevated…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #108 · Meta › Site feedback · 23 Mar 2026 · 0 likes Coming back to post #106, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #19 · Analytics › Mass spectrometry · 20 Mar 2026 · 33 likes What mass accuracy establishes: the measured mass is consistent with a specific composition. What it does not establish: purity, sequence order, stereochemistry, or the…
-
[2026 update] What a purity-only report leaves out Replied, post #59 · Sourcing › Independent verification · 19 Mar 2026 · 0 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
-
Reading an interaction checker output critically Replied, post #142 · Practice › Interactions · 10 Mar 2026 · 0 likes Picking up post #139: that is the part I would want checked first. Thyroid medications: semaglutide is associated with a slowing of gastric emptying, which might affect…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #35 · Compounds › Tirzepatide · 6 Mar 2026 · 17 likes Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a…
-
[2026 update] Availability by country, dated, with primary sources Replied, post #36 · Access › International · 5 Mar 2026 · 15 likes Insurance and coverage: coverage decisions are national. A compound approved in one country might not be covered by insurance in another. Checking both approval and…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #15 · Practice › Reconstitution · 16 Feb 2026 · 0 likes Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on injection. Isotonic solutions (close to blood osmolarity) are less…
-
Heterogeneity as information rather than as a nuisance Replied, post #83 · Evidence › Meta-analyses · 30 Jan 2026 · 3 likes When a meta-analysis is unhelpful: if the included studies are heterogeneous in population, intervention, or outcome, pooling them produces a number that represents…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #109 · Analytics › Home & field testing · 18 Jan 2026 · 32 likes Immunoassay limitations: tests that use antibodies have cross-reactivity limitations. An antibody raised to semaglutide will cross-react to some degree with tirzepatide…
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #45 · Practice › Side effects · 17 Jan 2026 · 0 likes I read post #43 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
How to read a forest plot, properly, from scratch Replied, post #70 · Evidence › Trials · 14 Dec 2025 · 1 like Open-label design: unblinded trials admit expectation effects. For weight-loss trials where one arm loses substantial weight and the other does not, complete blinding…
-
Why oral semaglutide needs an absorption enhancer at all Replied, post #57 · Compounds › Oral incretins · 10 Dec 2025 · 15 likes This follows post #54 rather than contradicting it. Why an oral formulation is a formulation achievement: the molecule is the same but the tablet is novel. Getting a…
-
Specification in the result column: why that is a meaningful error Replied, post #79 · Analytics › COA interpretation · 26 Nov 2025 · 26 likes When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at 214 nm on a C18 column with a 10 to 40% acetonitrile gradient…
-
Waist circumference technique and its repeatability Replied, post #11 · Outcomes › Progress reports · 29 Oct 2025 · 4 likes This follows post #8 rather than contradicting it. Menstrual cycle: for people who menstruate, weight can shift by several pounds across the cycle due to fluid…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #135 · Compounds › Tirzepatide · 25 Oct 2025 · 2 likes post #134 is right about the mechanism and I think understates the practical bit. Storage and stability: published data on licensed tirzepatide formulations exists and…
-
Why a compound being unapproved is not the same as being illegal to possess Replied, post #23 · Sourcing › Regulatory · 10 Oct 2025 · 8 likes I read post #21 twice before replying, because I had assumed the opposite. Labelling and intended use: a compound sold as "research-use-only" does not change its…
-
Non-inferiority margins: how they are chosen and how they are abused Started this topic · Evidence › Trials · 16 Sep 2025 · 6 likes Posting this under the heading it deserves: Non-inferiority margins: how they are chosen and how they are abused Everything below is what sits behind that. Comparing…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #30 · Lounge › Off topic · 11 Sep 2025 · 6 likes Not a rules-free zone: the guidelines still apply. No phones, no Telegram, no endorsements of other communities. Just a relaxed bar for how directly the topic needs to…
-
When a preprint is the best available evidence and we say so Replied, post #148 · Evidence › Preprints · 6 Sep 2025 · 0 likes This follows post #145 rather than contradicting it. Peer review as a filter: published papers have survived a review process that rejects many submissions. Preprints…
-
What pooling buys you and what it destroys Replied, post #16 · Evidence › Meta-analyses · 5 Sep 2025 · 0 likes Funnel plots: a plot of study effect size versus sample size that helps detect publication bias. If small studies are missing on the negative side, the funnel is…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #4 · Compounds › Semaglutide · 1 Sep 2025 · 0 likes Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management indication is approved in many European jurisdictions but not all, and…
-
The "under review" status pill and when a moderator applies it — a second dataset Replied, post #49 · Evidence › Preprints · 26 Aug 2025 · 0 likes Unrefereed work is not worthless. A great deal of it survives review substantially unchanged. It is also the case that the version appearing in a journal frequently has…
-
A request that was declined, and the reasoning — a second dataset Replied, post #55 · Documentation › Wiki requests · 11 Aug 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
A request that was declined, and the reasoning — a second dataset Replied, post #15 · Documentation › Wiki requests · 6 Aug 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Follow-up: Why appetite effects are mostly central Replied, post #11 · Pharmacology › Receptor biology · 4 Aug 2025 · 1 like Worth separating two things that post #7 runs together. Glucagon receptor agonism: glucagon receptor agonism increases energy expenditure and promotes hepatic fat…
-
The C-cell question: rodent findings and their human context Replied, post #37 · Compounds › Semaglutide · 11 Jul 2025 · 12 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #68 · Evidence › Trials · 3 Jul 2025 · 0 likes Population narrowness: most trials in this class enrolled fairly specific groups. Baseline body mass index ranges, exclusion of renal disease, exclusion of certain…
-
Forced degradation studies: designing one that is informative — does this still hold? Replied, post #28 · Analytics › Method validation · 1 Jul 2025 · 5 likes post #27 answers the question as asked. The question underneath it is different. Linearity: the detector response is proportional to compound concentration across the…
-
Area percent versus weight percent: the confusion that causes most arguments — what… Replied, post #7 · Analytics › HPLC & UHPLC · 23 Jun 2025 · 0 likes Column chemistry and particle size: smaller particles (1.7 μm) give better resolution and higher efficiency than larger particles (3.5 μm or 5 μm), at the cost of…
-
The report format the maintainers ask for, and why each field is there — what changed… Replied, post #34 · Sourcing › Vendor reports · 12 Jun 2025 · 0 likes Testing service selection: Janoshik gives purity with chromatogram. Medutest gives combined purity and identity. PeptideMeter gives verification records as well as…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #33 · Compounds › Repair & healing peptides · 7 Jun 2025 · 9 likes post #32 answers the question as asked. The question underneath it is different. The distinction between "no evidence it works" and "evidence it does not work": we have…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #116 · Access › Pricing · 27 May 2025 · 0 likes Compute cost per delivered dose at your dose if you want a number you can act on. That requires knowing your dose, vial volume, and whether you are using a vial or a pen.
-
A ten-fold dose error caught before injection Replied, post #40 · Devices › Syringes & needles · 27 May 2025 · 0 likes On post #36 — agreed on the reasoning, with one qualification. Dead volume: residual liquid in the hub and needle after withdrawal. Typical residual is 0.01 to 0.02 mL…
-
A report I filed that turned out to be wrong, and the correction Replied, post #27 · Sourcing › Vendor reports · 25 Apr 2025 · 7 likes I read post #25 twice before replying, because I had assumed the opposite. Multiple services on one lot: agreement across two independent laboratories is stronger than…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #78 · Sourcing › Red flags · 10 Apr 2025 · 5 likes Anonymity: a supplier that will not disclose legal name, address, or responsible person is not operating in a way that allows accountability.
-
A certificate with no method stated: what can you conclude? Replied, post #40 · Analytics › COA interpretation · 7 Apr 2025 · 5 likes Coming back to post #38, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Carryover and the ghost peak from last week's standard Replied, post #23 · Analytics › HPLC & UHPLC · 3 Apr 2025 · 0 likes Detection wavelength: 214 nm detects the peptide bond and is relatively insensitive to composition. 280 nm detects aromatic residues and is strongly…
-
Distinguishing a deletion sequence by mass alone Replied, post #49 · Analytics › Mass spectrometry · 4 Feb 2025 · 9 likes Mass accuracy is expressed in parts per million. It is the difference between observed and theoretical mass divided by theoretical mass, multiplied by a million. A…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #27 · Evidence › Meta-analyses · 30 Jan 2025 · 2 likes Picking up post #24: that is the part I would want checked first. Why forest plots are more informative than pooled numbers: they show the variation across studies,…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #67 · Analytics › COA interpretation · 27 Jan 2025 · 8 likes Worth separating two things that post #63 runs together. Sterility testing is separate: chromatographic purity, mass spectrometry, and endotoxin testing all say nothing…
-
When "no data" is the complete and final answer Replied, post #68 · Compounds › Other compounds · 17 Jan 2025 · 2 likes This subcategory exists because some people will research compounds outside the main groups discussed here. The standard of evidence and honesty about its limits…
-
Fibre intake when total intake falls, and the constipation link Replied, post #15 · Nutrition & Training › Protein & intake · 9 Jan 2025 · 3 likes Protein supplements: whey, casein, and plant-based protein powders can help hit targets when whole-food intake is limited by appetite. Protein quality (all essential…
-
Body image changing more slowly than the body Replied, post #114 · Wellbeing › Mental health · 23 Dec 2024 · 1 like For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Coming back to: Research-use-only labelling: what it means and what it does not Replied, post #47 · Sourcing › Regulatory · 5 Dec 2024 · 12 likes Labelling and intended use: a compound sold as "research-use-only" does not change its pharmacology if ingested. It changes the legal status of the sale. The labelling…
-
A side-effect grading scheme this community uses, and its limits — the long version Replied, post #19 · Practice › Side effects · 26 Nov 2024 · 11 likes Gallbladder complications: rapid weight loss increases the risk of gallstone formation. The mechanism is not specific to this drug class. The risk is greatest in the…
-
Revisiting: Moderation log format change Replied, post #37 · Meta › Announcements · 22 Nov 2024 · 13 likes Staff announcements, policy changes, and scheduled maintenance. Read-only except for questions clarifying what was announced.
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #106 · Compounds › Repair & healing peptides · 21 Nov 2024 · 13 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #4 · Clinical › Special populations · 18 Nov 2024 · 1 like Pregnancy and planning: these compounds are not approved for use in pregnancy. Planning windows (how long to wait before attempting pregnancy) are not formally…
-
Buffers, pH and why a formulation is a formulation Replied, post #11 · Pharmacology › Formulation chemistry · 29 Oct 2024 · 1 like Emulsification and suspensions: some formulations are emulsions or suspensions rather than solutions. Semaglutide formulations are solutions; some other compounds are…
-
The C-cell question: rodent findings and their human context — what changed since Replied, post #58 · Compounds › Semaglutide · 18 Sep 2024 · 5 likes Gastric emptying delay is the mechanism behind most of the gastrointestinal side effects. Slowing the stomach empties it feeds less food into the intestines at a time,…
-
Converting between mg/mL and units per dose, both directions Replied, post #6 · Practice › Reconstitution · 29 Aug 2024 · 5 likes The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most common arithmetic error in this subcategory. The habit that catches it:…
-
High-resolution MS on aggregates and what it can see — one year on Replied, post #20 · Analytics › Mass spectrometry · 13 Aug 2024 · 1 like Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS, because extinction coefficients are better known. MS can quantify if an internal…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #19 · Clinical › Prescriber conversations · 12 Jul 2024 · 2 likes Discussing off-label dosing: if you want to dose differently than the label specifies (slower titration, higher final dose), discussing that explicitly and…